The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Comerica Bank

Comerica Bank increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 7.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,559 shares of the medical device company's stock after buying an additional 5,611 shares during the quarter. Comerica Bank's holdings in Cooper Companies were worth $7,130,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Fulton Bank N.A. grew its position in shares of Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after purchasing an additional 109 shares in the last quarter. Covestor Ltd raised its position in Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the period. Torray Investment Partners LLC lifted its stake in Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock worth $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. boosted its holdings in Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after acquiring an additional 133 shares during the period. Finally, MassMutual Private Wealth & Trust FSB increased its stake in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after purchasing an additional 136 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have issued reports on COO. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Citigroup decreased their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Robert W. Baird dropped their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research report on Friday, March 7th. Finally, JPMorgan Chase & Co. cut their price target on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Stock Performance

Shares of NASDAQ:COO traded down $0.27 during midday trading on Friday, hitting $82.65. The stock had a trading volume of 474,055 shares, compared to its average volume of 1,440,321. The stock has a 50 day moving average price of $80.71 and a two-hundred day moving average price of $91.19. The company has a market capitalization of $16.53 billion, a PE ratio of 42.38, a P/E/G ratio of 2.25 and a beta of 1.08. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.